Save time and get answers to complex questions with AI chat
Patent expiry trametinib?Drugpatentwatch crizotinib?Guselkumab brand name?Antiox mebendazole price?What is the difference between apixaban and apixaban accord?
See the DrugPatentWatch profile for Kisqali
Do you mean the US launch date or a different region (EU, UK, etc.)? Briefly: Kisqali (ribociclib) was approved by the U.S. FDA in March 2017 (FDA press release dated March 13, 2017) and launched in the US shortly after in 2017. If you specify a region, I can give the exact launch date for that market.
Other Questions About Kisqali :